BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3488123)

  • 1. Augmentation of the generation of cell-mediated cytotoxicity after a single dose of adriamycin in cancer patients.
    Arinaga S; Akiyoshi T; Tsuji H
    Cancer Res; 1986 Aug; 46(8):4213-6. PubMed ID: 3488123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of the cell-mediated cytotoxic response induced in mixed cell culture by adriamycin.
    Arinaga S; Akiyoshi T; Tsuji H
    Jpn J Cancer Res; 1985 May; 76(5):414-9. PubMed ID: 3159614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression of the generation of cell-mediated cytotoxicity by suppressor cells after surgery.
    Miyazaki S; Akiyoshi T; Arinaga S; Koba F; Wada T; Tsuji H
    Clin Exp Immunol; 1983 Nov; 54(2):573-9. PubMed ID: 6228356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients.
    Wright SC; Jewett A; Mitsuyasu R; Bonavida B
    J Immunol; 1988 Jul; 141(1):99-104. PubMed ID: 3132506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer.
    Robertson MJ; Cameron C; Atkins MB; Gordon MS; Lotze MT; Sherman ML; Ritz J
    Clin Cancer Res; 1999 Jan; 5(1):9-16. PubMed ID: 9918197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of the development of immune responses of mice against allogeneic tumor cells after adriamycin treatment.
    Tomazic V; Ehrke MJ; Mihich E
    Cancer Res; 1981 Sep; 41(9 Pt 1):3370-6. PubMed ID: 7260903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between adriamycin-induced augmentation of interleukin 2 production and of cell-mediated cytotoxicity in mice.
    Ehrke MJ; Maccubbin D; Ryoyama K; Cohen SA; Mihich E
    Cancer Res; 1986 Jan; 46(1):54-60. PubMed ID: 3484381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular basis for adriamycin-induced augmentation of cell-mediated cytotoxicity in culture.
    Ehrke MJ; Ryoyama K; Cohen SA
    Cancer Res; 1984 Jun; 44(6):2497-504. PubMed ID: 6426781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression of the generation of cell-mediated cytotoxicity in regional lymph nodes of patients with gastric carcinoma.
    Koba F; Akiyoshi T; Tsuji H
    J Clin Lab Immunol; 1987 Apr; 22(4):181-4. PubMed ID: 3497276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [NK activity, TCGF production and generation of cell-mediated cytotoxicity in spleen cells from gastric cancer patients].
    Akiyoshi T; Koba F; Miyazaki S; Arinaga S; Tsuji H
    Nihon Geka Gakkai Zasshi; 1983 Sep; 84(9):957-60. PubMed ID: 6610103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12.
    Bose A; Baral R
    Hum Immunol; 2007 Oct; 68(10):823-31. PubMed ID: 17961770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin.
    Kornbluth RS; Edgington TS
    J Immunol; 1986 Oct; 137(8):2585-91. PubMed ID: 3760568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics.
    Bloom ET; Babbitt JT; Kawakami K
    J Immunol; 1986 Jul; 137(1):172-8. PubMed ID: 3711665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
    Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
    Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
    Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of human natural killer cell function by L-leucine methyl ester: monocyte-dependent depletion from human peripheral blood mononuclear cells.
    Thiele DL; Lipsky PE
    J Immunol; 1985 Feb; 134(2):786-93. PubMed ID: 3965574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of interferon-gamma production by human natural killer cells stimulated by hydrogen peroxide.
    Munakata T; Semba U; Shibuya Y; Kuwano K; Akagi M; Arai S
    J Immunol; 1985 Apr; 134(4):2449-55. PubMed ID: 3919096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated killer cell activity in lymph nodes.
    Akiyoshi T; Koba F; Tsuji H
    J Clin Lab Immunol; 1987 Feb; 22(2):91-5. PubMed ID: 3496459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human peripheral blood monocyte and bronchoalveolar macrophage cytotoxicity for cultured human lung tumor cells.
    Swinburne S; Cole P
    J Reticuloendothel Soc; 1982 Nov; 32(5):371-85. PubMed ID: 6761437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.